Park, Sohee, Jeong, Han Eol, Lee, Hyesung, You, Seng Chan and Shin, Ju-Young (2023). Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes:a cohort study. Cardiovascular Diabetology, 22 (1),
Abstract
BACKGROUND: Given the cumulative evidence on the effectiveness of sodium-glucose cotransporter 2 inhibitors (SGLT2is) on chronic heart failure, demand is emerging for further information on their effects in patients who are hospitalized for acute heart failure. However, there is still limited evidence about the class effect of SGLT2is on acute heart failure. We investigated whether initiating treatment with SGLT2is after an episode of acute heart failure reduces the risks of post-discharge heart failure readmission or cardiovascular mortality among patients with type 2 diabetes. METHODS: A retrospective cohort study was conducted in a cohort of patients with type 2 diabetes who hospitalized for heart failure, using Korean Health Insurance Review & Assessment database (2015-2020). The exposure was defined as initiation of SGLT2is during hospitalization or at discharge. We assessed hazards of post-discharge heart failure readmission and cardiovascular death at 1-year, and 30-, 60-, and 90-day from the date of discharge in the SGLT2is users and non-users. Cox proportional hazards models with propensity score-based inverse probability of treatment weighting were used to estimate hazard ratios and 95% confidence intervals. RESULTS: Among 56,343 patients with type 2 diabetes hospitalized for heart failure, 29,290 patients were included in the study cohort (mean [SD] age, 74.1 [10.8] years; 56.1% women); 818 patients (2.8%) were prescribed SGLT2is during index hospitalization or at discharge. Patients with a prescription for SGLT2i vs. those without prescription had lower rates of heart failure readmission or cardiovascular death at 1 year (22.4% vs. 25.3%; adjusted hazard ratio, 0.90 [95% confidence interval, 0.87-0.93]), and also at 30 days (7.0% vs. 7.7%%; 0.74 [0.69-0.79]). CONCLUSIONS: Among patients with type 2 diabetes, initiating SGLT2i treatment after an episode of acute heart failure was significantly associated with a reduced combined risk of heart failure readmission and cardiovascular mortality in a nationwide cohort reflecting routine clinical practice.
Publication DOI: | https://doi.org/10.1186/s12933-023-01896-3 |
---|---|
Divisions: | College of Health & Life Sciences > Aston Pharmacy School College of Health & Life Sciences |
Funding Information: | This work was supported by a grant (21153MFDS607) from Ministry of Food and Drug Safety of South Korea in 2021–2025. This study was supported by a grant (22213MFDS486) from the Ministry of Food and Drug Safety, South Korea, in 2022–2023 |
Additional Information: | © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License |
Uncontrolled Keywords: | Humans,Female,Aged,Male,Diabetes Mellitus, Type 2/diagnosis,Cohort Studies,Patient Discharge,Retrospective Studies,Aftercare,Sodium-Glucose Transporter 2 Inhibitors/adverse effects,Heart Failure/diagnosis,Glucose,Sodium |
Publication ISSN: | 1475-2840 |
Data Access Statement: | The data that support the findings of this study are available from the Health Insurance Review and Assessment Service of South Korea but restrictions apply to the availability of these data due to domestic laws and regulations that prohibit the distribution or release of individual’s data to the public, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the Health Insurance Review and Assessment Service of South Korea. |
Last Modified: | 16 Aug 2024 07:17 |
Date Deposited: | 17 Jul 2024 13:27 |
Full Text Link: | |
Related URLs: |
https://cardiab ... 933-023-01896-3
(Publisher URL) |
PURE Output Type: | Article |
Published Date: | 2023-07-28 |
Accepted Date: | 2023-06-20 |
Authors: |
Park, Sohee
(![]() Jeong, Han Eol Lee, Hyesung You, Seng Chan Shin, Ju-Young |